Clinical trial
Safety Study of UC-781 Vaginal Microbicide
NCT00446979 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00446979 |
|---|---|
| Title | Safety Study of UC-781 Vaginal Microbicide |
| Official title | Phase I Study of the Safety and Acceptability of UC-781 Topical Vaginal Microbicide in Women and Acceptability in Their Male Partners,Chiang Rai, Thailand |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Ministry of Health, Thailand CONRAD |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Placebo gel, UC 781 |
| Enrollment | 90 |
| Start date | Jun 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Mar 13, 2007 |
| Last update posted | Apr 19, 2013 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: